Model
Edge
Alnylam Pharmaceuticals, Inc.
0001782962
Filing Type
4
Filing Date
6/25/2024
Updated
6/26/24, 2:26 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership